The Bottom Line

PCOS affects skin dramatically through excess androgens and insulin resistance. The most common skin manifestations are hormonal acne (along the jawline), hirsutism (unwanted facial and body hair), androgenic hair loss (scalp thinning), and acanthosis nigricans (dark, velvety patches in skin folds). Treating the underlying hormonal imbalance — not just the skin symptoms — produces the best long-term results.

How PCOS Affects Your Skin

PCOS involves two key metabolic disturbances that impact skin:

1. Excess androgens (hyperandrogenism):

  • Stimulate sebaceous glands → increased oil → acne
  • Promote terminal hair growth on face/body → hirsutism
  • Cause scalp follicle miniaturization → hair thinning

2. Insulin resistance (affects 60-80% of women with PCOS):

  • High insulin stimulates ovarian androgen production (worsening the above effects)
  • Causes acanthosis nigricans (dark, velvety skin in folds)
  • Promotes skin tags
  • May worsen acne through IGF-1 pathway

Common Skin Manifestations

Acne: Affects about 30% of PCOS patients. Typically deep, inflammatory, cystic lesions on the jawline, chin, and lower cheeks. Often resistant to standard acne treatments because the hormonal driver isn't addressed.

Hirsutism: Affects 60-80% of PCOS patients. Coarse, dark hair on the upper lip, chin, chest, abdomen, and back. Often the most distressing symptom for patients.

Androgenic alopecia: Scalp hair thinning in up to 40% of PCOS patients. Typically a widening part line with diffuse thinning on top, maintaining the frontal hairline.

Acanthosis nigricans: Dark, thickened, velvety skin patches in the neck creases, armpits, groin, and under the breasts. A marker of insulin resistance. Found in 30-50% of PCOS patients.

Skin tags (acrochordons): Small, soft, flesh-colored growths commonly found on the neck, armpits, and groin. Associated with insulin resistance.

Treatment Approach

Addressing the root cause:

  • Weight management: Even 5-10% weight loss in overweight women significantly reduces androgens and insulin levels
  • Low-glycemic diet: Reduces insulin, which reduces androgen production
  • Metformin (500-2000mg daily): Improves insulin sensitivity, reduces androgens. Skin benefits develop over 3-6 months.
  • Inositol (myo-inositol 2-4g daily): Improves insulin sensitivity with fewer side effects than metformin

Targeted skin treatments:

  • For acne: Spironolactone (50-200mg) + combined oral contraceptive + topical retinoid
  • For hirsutism: Spironolactone + laser hair removal (Nd:YAG for dark skin, alexandrite for lighter skin)
  • For hair loss: Minoxidil 5% + spironolactone
  • For acanthosis nigricans: Improves primarily with insulin resistance treatment (metformin, weight loss). Topical retinoids and ammonium lactate can improve appearance.

Frequently Asked Questions

Will treating PCOS clear my skin?

Addressing the hormonal and metabolic imbalance (with spironolactone, birth control, metformin, and lifestyle changes) significantly improves skin in most women. However, complete clearance may require combining systemic treatment with topical skincare. Improvement takes 3-6 months — be patient.

Is acanthosis nigricans permanent?

No. It's reversible when insulin resistance improves. Weight loss, metformin, and dietary changes can noticeably lighten dark patches over months. Topical treatments (tretinoin, ammonium lactate) can speed cosmetic improvement.

Should I see a dermatologist or an endocrinologist?

Ideally both. An endocrinologist or gynecologist manages the overall hormonal and metabolic aspects of PCOS. A dermatologist provides targeted skin-specific treatments. Many dermatologists are experienced in managing PCOS skin conditions independently, prescribing spironolactone and oral contraceptives alongside topical treatments.

  1. Azziz R, et al. "Polycystic ovary syndrome." Nature Reviews Disease Primers. 2016;2:16057.
  2. Yildiz BO. "Assessment, diagnosis, and treatment of a patient with hirsutism." Nature Clinical Practice Endocrinology & Metabolism. 2008;4(5):294-300.
  3. Buzney E, et al. "Polycystic ovary syndrome: a review for dermatologists." JAAD. 2014;71(5):847.e1-10.